2.3.1.B41	(4R)-1-[(benzyloxy)carbonyl]-4-hydroxy-L-prolyl-N6-ethanethioyl-N-phenyl-L-lysinamide	0.2 mM, 56% inhibition, substrate: Ac-RYQ(N6-acetyl)K-7-amido-4-methylcoumarin	196340	
2.3.1.B41	(9H-fluoren-9-yl)methyl(6-acetamido-1-(dodecylamino)-1-oxohexan-2-yl)carbamate	-	245404	
2.3.1.B41	(9H-fluoren-9-yl)methyl(6-acetamido-1-(dodecylamino)-1-oxohexanyl) carbamate	-	247434	
2.3.1.B41	1-(4,5-dihydropyrrolo[1,2-a]quinoxalin-4-yl)naphthalen-2-ol	-	245472	
2.3.1.B41	1-(tert-butoxycarbonyl)-L-prolyl-N6-ethanethioyl-N-phenyl-L-lysinamide	0.2 mM, 32% inhibition, substrate: Ac-RYQ(N6-acetyl)K-7-amido-4-methylcoumarin	196341	
2.3.1.B41	2,4-dioxo-N-(4-(pyridin-3-yloxy)phenyl)-1,2,3,4-tetrahydroquinazoline-6-sulfonamide	i.e. compound Q, a SIRT6 inhibitor with quinazolinedione-like structure, which reduces both SIRT6 deacetylase and deacylase activities	247435	
2.3.1.B41	2,6-diamino-N-dodecylhexanamide	-	245520	
2.3.1.B41	2,6-diamino-N-octadecylhexanamide	-	245521	
2.3.1.B41	2-acetamido-6-amino-N-octadecylhexanamide	-	245631	
2.3.1.B41	2-acetamido-6-amino-N-tetradecylhexanamide	-	247433